Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
-67.1K
-
Total reported value, excl. options
-
$166M
-
Value change
-
-$1.19M
-
Put/Call ratio
-
2.51
-
Number of buys
-
46
-
Number of sells
-
-25
-
Price
-
$16.18
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q4 2019
89 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q4 2019.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 48M outstanding shares and own 21.42% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (2.47M shares), Park West Asset Management LLC (871K shares), VANGUARD GROUP INC (626K shares), AMERIPRISE FINANCIAL INC (601K shares), SANDLER CAPITAL MANAGEMENT (568K shares), Russell Investments Group, Ltd. (556K shares), BlackRock Inc. (555K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (476K shares), Ranger Investment Management, L.P. (300K shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (278K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.